BIVIW vs BMY
BioVie Inc. Warrant (BIVIW) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
BioVie Inc. Warrant (BIVIW) common stock listed on NASDAQ.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
BIVIW does not have a complete income-statement cache yet.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BIVIW currently screens at market cap $0. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BIVIW and BMY stock pages for the full models.
Not investment advice.